Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
1 other identifier
observational
100
1 country
1
Brief Summary
Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 2, 2012
CompletedFirst Posted
Study publicly available on registry
March 7, 2012
CompletedMarch 7, 2012
January 1, 2009
March 2, 2012
March 6, 2012
Conditions
Study Arms (1)
HIV-cancer patients who recived RT
Interventions
External photon beam radiation therapy dosage 4000-7000 CGy
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up
Eligibility Criteria
HIV positive cancer patients Curative RT treatment
You may qualify if:
- Age 18-65 years
- HIV positive cancer patients
- Photon beam RT, conventional fraction \>= 4000 cgy in 4 weeks
You may not qualify if:
- CD4 count \< 200 cell/ml and not received anti retro viral
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rajavithi Hospital
Bangkok, Bangkok, 10400, Thailand
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2012
First Posted
March 7, 2012
Study Start
August 1, 2009
Last Updated
March 7, 2012
Record last verified: 2009-01